UK 3D Imaging Market Analysis Report 2022 to 2030

UK 3D Imaging Market Analysis

$ 3999

The UK 3D imaging market is projected to grow from $0.79 Bn in 2022 to $2.33 Bn by 2030, registering a CAGR of 14.5% during the forecast period of 2022-30. The market will be driven by technological advancements and government initiatives to promote the same. The market is segmented by product, application, end-user & by portability. Some of the major players include Philips Healthcare, GE Healthcare & Vision RT Ltd.

ID: IN10GBDH001 CATEGORY: Digital Health GEOGRAPHY: UK AUTHOR: Vidhi Upadhyay

Buy Now

UK 3D Imaging Market Executive Summary

The UK 3D imaging market is projected to grow from $0.79 Bn in 2022 to $2.33 Bn by 2030, registering a CAGR of 14.5% during the forecast period of 2022-30. Healthcare spending in the UK as a share of GDP has raised by 10.15% in 2019 from 9.81% in 2017 as given by the World Health Organization Global Health Expenditure database and has expanded the spending nearly to 11.9% of GDP in 2021 which is much higher compared to the time before COVID -19 impacted the country’s economy. Coronary Heart Disease (CHD) is the most common cause of death (and premature death) in the UK with 7.6 million individuals living with heart and circulatory problems. Also, the number of people living with cancer was estimated to be 3 Mn and is expected to rise to 4 Mn by the year 2030.

3D imaging is used to diagnose and evaluate a wide range of medical diseases, including cancer, cardiovascular disease, and orthopedic complications. Some of the most frequent diagnostic imaging procedures in the UK are CT scans, MRIs, and PET scans. In the healthcare sector, 3D imaging is being used for diagnostic purposes, planning, and simulation, treatment guidance, image-guided surgeries & for research and training. In the UK, the demand for these services is expected to grow in the coming years. In January 2023, Bayer purchased Blackford Analysis Ltd. (Edinburgh, UK), a worldwide strategic imaging AI platform and solutions supplier. The purchase is part of Bayer's plan to promote radiology innovation, including the advancement and deployment of AI inside clinical workflows.

In May 2021, NHS England announced the implementation of HeartFlow, a 3D imaging technology, to detect and treat over 1,000 individuals with suspected heart disease. HeartFlow, a component of the NHS Long Term Plan, converts a standard CT scan of the heart into a 3D picture. It thus allows physicians to identify potentially fatal coronary heart disease in only 20 minutes. In February 2020, The UK government allocated $105 million to support 3D medical imaging equipment that could generate X-rays in under 40 seconds.

UK 3D imaging market analysis

Market Dynamics

Market Growth Drivers

In July 2022, Researchers from the UK innovated a low-cost device that could aid 3D pictures of eyes and is capable of transforming eye screening procedures across the globe. It is expected to eventually also be utilized to detect eye cancer. The high prevalence of CVD in the UK, as well as government-supported efforts to encourage breast screening, are driving market expansion. Technological advancements have increased the quality of pictures provided by high-resolution imaging technologies such as CT and MRI scanners. Moreover, the rising prevalence of chronic illnesses, as well as government assistance for the health industry, have fuelled demand for 3D imaging. Furthermore, the rising trend towards less invasive treatments, as well as enhanced information and awareness about the benefits of 3D imaging, are driving market expansion. These factors are projected to fuel expansion in the UK 3D imaging market in the coming years.

Market Restraints

One of the primary barriers to 3D imaging is its high cost, which includes the cost of imaging equipment as well as the cost of maintenance and training. The high expense of this technology may make it challenging for healthcare providers, especially small organizations, to embrace it. Concerns about privacy and security arise when sensitive patient information, such as medical photographs, is handled. Strict privacy and security safeguards must be in place. Inadequate security measures and privacy violations could have major implications, including loss of patient confidence and monetary loss. In the UK, compensation regulations for 3D imaging services can be difficult to navigate, and healthcare professionals may not be fairly compensated for the services they perform. This can limit the usage of 3D imaging, especially in circumstances when money is scarce.

Competitive Landscape

Key Players

Philips Healthcare
GE Healthcare
Siemens Healthineers
Hitachi Healthcare
Toshiba Medical Systems
Vision RT Ltd. (GBR)
Pure Medical Imaging (GBR)

Notable Deals

November 2022, Philips enhanced AI-powered diagnostic technologies and transformational workflow solutions at RSNA 2022.
In October 2022, Philips revealed two significant advancements in MR-only procedures for head and neck cancer radiation imaging and simulation.
In September 2022, GE Healthcare’s deep-learning 3D imaging system received FDA-expanded approval. Also, it’s “AIR Recon DL” Received FDA Approval for 3D and Motion-Insensitive Imaging Applications for Superior Image Quality and Patient Experience in MRI

Healthcare Policies and Regulatory Landscape

In the UK, the use of 3D imaging is governed by numerous organizations, including the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE). These organizations are in charge of establishing standards and recommendations for medical imaging equipment and services, including 3D imaging. The MHRA also regulates the marketing and distribution of medical devices in the UK. NICE assesses the clinical and economic efficacy of new and established healthcare technology and makes recommendations for their usage in the NHS.

Reimbursement Scenario

In the UK, the reimbursement for 3D imaging is initially determined by the National Institute for Health and Care Excellence (NICE). If NICE recommends a 3D imaging technique, it is then reimbursed by the NHS. The NHS is the UK's public healthcare system that serves the majority of the population, including 3D imaging operations. Private medical insurance often allows coverage for 3D imaging operations in the private healthcare sector. Individuals with private health insurance have the option of having their imaging procedures conducted in private hospitals or clinics, where they have access to a broader selection of services and facilities.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.